Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries

By Marta Pereira, N. Lunet, A. Azevedo, H. Barros. Journal of Hypertension, 2009

622 citations recorded by the source corpus.

Subfields: Education, Management Information Systems

View Paper: https://www.semanticscholar.org/paper/a9ebc22187bd2657051cd7e0103639e0442fd11f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Mancia
2. R. Fagard
3. S. Daskalopoulou
4. M. Tendera
5. A. Dominiczak
6. R. Cífková
7. G. De Backer
8. K. Narkiewicz

Citations in the corpus

• ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “sion and the temporal trends of BP values in different European countries.(16) Overall the prevalence of hypertension appears to be around 30–45% of the general population, with a steep increase with ageing.”
• Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health (2010, background): “found that more than 80 percent of the attributable burden of hypertension in 2001 occurred in low and middle income countries (2008), and both another recent review and an analysis commissioned for this report found the prevalence of hypertension to be equally high in developed and developing count”
• The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “3 Prevalence of hypertension Limited comparable data are available on the prevalence of hypertension and the temporal trends of BP values in different European countries [16].”
• 2013 ESH/ESC Guidelines for the management of arterial hypertension (2007, neutral): “3 A magas vérnyomás prevalenciája Korlátozottan állnak rendelkezésre összehasonlító adatok a magas vérnyomás prevalenciájáról és a vérnyomásértékek idôbeli tendenciáiról a különbözô európai országokban [16].”
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Despite overwhelming evidence that hypertension is a major CV risk factor and that BP-lowering strategies substantially reduce the risk, studies performed outside Europe and in several European countries [16,683] consistently show that (i) a noticeable proportion of hypertensive individuals are unaw”